Future Medicine

Developer of therapies for treating inflammation, fibrosis, and cancer

placeSeoul, Seoul, South Korea calendar_todayFounded 2015 groups18 employees language futuremedicine.co.kr

Innovation

23 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 401 times.

YearFilings
20131
20175
20186
20196
20205
20215
20228
20239
20248
20253
20262

Investor mix

6 investors on record; lead investors include Kolon Investments, Wooshin Venture Investment, NH Investment & Securities.

Investor typeCountShare
Venture capital350%
Private equity233%
Bank & private debt117%
Coming soon